Results 71 to 80 of about 6,764,527 (311)

New technologies to improve CAR T cell generation and biomanufacturing will lead to safer, more therapeutically effective cells

open access: yes, 2021
Clinical trials, including chimeric antigen receptor (CAR) T cell therapy for a range of terminal tumors, are now ongoing in several locations across the world, and the commercialization of some of these therapies is likely to begin in the near future.
openaire   +1 more source

International mobility of women in science and technology careers: shaping plans for personal and professional purposes [PDF]

open access: yes, 2017
International mobility has become a key requirement in science and technology (S&T) professional career progression. On the one hand, the increasing mobility of women suggests that this may be a way for them to avoid or get away from women-unfriendly ...
González Ramos, Ana M.   +1 more
core   +1 more source

CDK11 inhibition induces cytoplasmic p21WAF1 splice variant by p53 stabilisation and SF3B1 inactivation

open access: yesMolecular Oncology, EarlyView.
CDK11 inhibition stabilises the tumour suppressor p53 and triggers the production of an alternative p21WAF1 splice variant p21L, through the inactivation of the spliceosomal protein SF3B1. Unlike the canonical p21WAF1 protein, p21L is localised in the cytoplasm and has reduced cell cycle‐blocking activity.
Radovan Krejcir   +12 more
wiley   +1 more source

Knocked out by Rho/Rac T-cell biology [PDF]

open access: yes, 2012
The Rho/Rac family is a group of Ras-related proteins with demonstrated roles in the regulation of proliferation and cytoskeletal structures in a number of cell lineages.
Bustelo, Xosé R.
core  

Quartz technology in Scottish prehistory

open access: yesScottish Archaeological Internet Reports, 2016
The project Quartz Technology in Scottish Prehistory was initiated in the year 2000, and over the following five years a large number of quartz assemblages were examined from all parts of Scotland, and from all prehistoric periods. The general aim of the
A. Saville, T. Ballin
semanticscholar   +1 more source

Reduced vascular leakage correlates with breast carcinoma T regulatory cell infiltration but not with metastatic propensity

open access: yesMolecular Oncology, EarlyView.
A mouse model for vascular normalization and a human breast cancer cohort were studied to understand the relationship between vascular leakage and tumor immune suppression. For this, endothelial and immune cell RNAseq, staining for vascular function, and immune cell profiling were employed.
Liqun He   +8 more
wiley   +1 more source

Comparative study of distributed implementation using Tuple space technology of two t-way test suite generation strategies

open access: yesInternational Journal of Physical Sciences, 2012
This paper highlights a comparative study of two new distributed t-way test suite generation strategies, called test suite generator one parameter (TS_OP) and test suite generator one test (TS_OT). Both strategies adopt computational greedy algorithm and were implemented on distributed shared memory environment using Tuple space technology.
openaire   +1 more source

Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107

open access: yesMolecular Oncology, EarlyView.
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz   +15 more
wiley   +1 more source

Fixed and Mobile Phoning in Italian Regions [PDF]

open access: yes
The telecommunication diffusion and it?s interaction with the socio-economic environment was analysed both in terms of introduction of new technologies in the market and their diffusion/substitution process with respect to former technologies ...
Carlo Tesauro   +2 more
core  

Class IIa HDACs forced degradation allows resensitization of oxaliplatin‐resistant FBXW7‐mutated colorectal cancer

open access: yesMolecular Oncology, EarlyView.
HDAC4 is degraded by the E3 ligase FBXW7. In colorectal cancer, FBXW7 mutations prevent HDAC4 degradation, leading to oxaliplatin resistance. Forced degradation of HDAC4 using a PROTAC compound restores drug sensitivity by resetting the super‐enhancer landscape, reprogramming the epigenetic state of FBXW7‐mutated cells to resemble oxaliplatin ...
Vanessa Tolotto   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy